3 Years On, Why Don’t We Know the Extent of Long COVID?
Amesh Adalja, MD, senior scholar, Johns Hopkins University Center for Health Security.
Manali Mukherjee, PhD, immunologist, assistant professor, Division of Respirology, Department of Medicine, McMaster University.
Sarah Wulf Hanson, PhD, research scientist, Institute for Health Metrics and Evaluation, University of Washington.
Lisa McCorkell, co-founder, Patient-Led Research Collaborative.
Julia Moore Vogel, PhD, program director, Participant Center, All of Us Research Program, Scripps Research Translational Institute.
The BMJ: “Long COVID outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study.”
Nature Reviews Microbiology: “Long COVID: Major findings, mechanisms and recommendations.”
CDC National Center for Health Statistics: “Long COVID Household Pulse Survey.”
Nature Medicine: “Unexplained post-acute infection syndromes.”
Patient-Led Research Collaborative.
World Health Organization: “Post COVID-19 condition (Long COVID).”
CDC: “Post-COVID Conditions: CDC Science.”
The European Respiratory Journal: “Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms.”
Emerging Infectious Diseases: “Postacute Sequelae of SARS-CoV-2 in University Setting.”
International Severe Acute Respiratory and emerging Infection Consortium (ISARIC): “Clinical Characterisation Protocol (CCP).”